To facilitate the production of D2E7, a breakthrough monoclonal for the treatment of arthritis, we delivered to Abbott this $35 million expansion, including an 8,000 square-foot warehouse additional. The 37,000 square-foot manufacturing facility was retrofitted into an existing shell, with Fluor providing multiple levels of engineering services, including process engineering for cell culture, harvest and purification. The facility also includes critical support functions such as CIP, WFI and clean steam.